Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Multiple pregnancies prevent skin disease but worsen kidney disease in certain mice.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

New therapies like JAK inhibitors and stem cells show promise in treating vitiligo.

Infliximab was effective in treating a scalp condition that did not respond to other treatments.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Methimazole can cause severe low platelet count in Graves' disease patients, so monitoring and alternative treatments are important.

Abrocitinib may effectively treat stubborn alopecia universalis.

JAK inhibitors can effectively regrow hair in alopecia areata patients, but ongoing treatment is needed to maintain results.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

ICI therapy increases the risk of gastrointestinal and endocrine issues in psoriasis patients.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Topical cyclosporin A may help treat psoriasis but has absorption and side effect challenges.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

The document concludes that various treatments for skin conditions are effective, but some require further research, and certain factors like gender and lifestyle can influence disease outcomes.

Injecting recipient splenocytes into donors' thymus can prevent graft-versus-host disease.

Oral cyclosporine works better than betamethasone minipulse therapy for treating Alopecia Areata.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Topical corticosteroids can help treat severe alopecia areata when other treatments fail.

Systemic steroids can effectively treat alopecia areata with manageable side effects.

The document concludes that diagnosing and treating Interstitial Pneumonia with Autoimmune Features (IPAF) is challenging, needs a multidisciplinary approach, and further research for better diagnostic criteria and treatments. It also emphasizes regular checks for Connective Tissue Disease symptoms in all patients with Interstitial Lung Disease.

Simvastatin/ezetimibe may help treat new cases of alopecia areata but not long-term cases.

New treatments like JAK inhibitors offer hope for better alopecia areata management.

Using anthralin and calcipotriene together might help treat tough cases of alopecia areata, but more research is needed to understand how it works.

Certain liver diseases respond well to specific treatments and have varying risks for liver cancer.

Microneedling may help treat some autoimmune skin conditions, but more research is needed.

Retinoids help treat psoriasis effectively, but they can cause side effects and need more research on safe use with other treatments.